COMMONWEALTH EQUITY SERVICES, LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 146 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 3.32 and the average weighting 0.0%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$55,000
-5.2%
10,165
-21.7%
0.00%
Q2 2022$58,000
-39.6%
12,990
-0.8%
0.00%
Q1 2022$96,000
+9.1%
13,090
-4.4%
0.00%
Q4 2021$88,000
+18.9%
13,690
+7.5%
0.00%
Q3 2021$74,000
-52.6%
12,740
+25.7%
0.00%
Q4 2020$156,000
-18.8%
10,134
+0.8%
0.00%
-100.0%
Q4 2019$192,000
+54.8%
10,052
-22.3%
0.00%0.0%
Q3 2019$124,00012,9370.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,180,700$137,941,00010.27%
Palo Alto Investors LP 4,299,901$82,601,0006.92%
Fairmount Funds Management LLC 562,351$10,803,0006.55%
Avoro Capital Advisors LLC 7,000,000$134,470,0004.54%
Pinz Capital Management, LP 8,820$1,694,0004.44%
Birchview Capital, LP 148,000$2,843,0002.52%
Elk Creek Partners, LLC 699,951$13,446,0002.31%
Parkman Healthcare Partners LLC 215,802$4,146,0001.92%
EAM Global Investors LLC 136,402$2,620,0001.53%
SPHERA FUNDS MANAGEMENT LTD. 550,000$10,566,0001.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders